Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 1
Court Won't Review Merck Summary Judgment in Vioxx Case
Judge Denies Plaintiffs' Motion To Reconsider Ruling Denying Remand
Judge Dismisses Claims Against Pharmacy That Dispensed Arthritis Drug
Merck Re-Submits Arcoxia Application After FDA Questions Cardio Safety
Physician Was Adequately Warned of Vioxx's Side Effects; Judge Awards Merck Summary Judgment
Plaintiff Failed to State Viable Claims Against Merck Sales Reps, Judge Denies Remand
Risk Management Issues Involving Arava: An Excerpt from Dr. Sidney Wolfe's Presentation Before the FDA Arthritis Advisory Committee
Texas Couple Moves to Remand Remicade Injury Case
